J&J Medical Connect
CARVYKTI®

(ciltacabtagene autoleucel)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

What Should I Mention to My Provider Before Starting CARVYKTI?

Last Updated: 04/11/2024

summary

Here is a passage from the CARVYKTI MEDICATION GUIDE which may be helpful to address your question1:

Before you receive CARVYKTI, tell your healthcare provider about all your medical conditions, including if you:

  • Have current or past neurologic problems (such as seizures, stroke, new or worsening memory loss).1
  • Have lung or breathing problems.1
  • Have heart problems.1
  • Have liver problems.1
  • Have kidney problems.1
  • Have a recent or active infection.1
  • Have low blood counts.1

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.1

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT MEDICATION GUIDE for CARVYKTI.1

 

References

1 CARVYKTI (ciltacabtagene autoleucel) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/CARVYKTI-pi.pdf.